Georgia Tech Research Corporation

Mercer University

Sheldon W May

Heath H Herman

James C Powers

Jan Glinski

Steven F Roberts

Steve Thornton

Maria A Hernandez

Stanley H Pollock

Robert S Phillips

Patricia W Mueller

Pharmaceutically acceptable compounds for administering to a subject, comprising the general structure II:wherein Ris an L-amino acid or salt or ester thereof, or an L-amino acid containing peptide or salt or ester thereof; and wherein the stereochemistry about the carbon-carbon double bond is trans. The invention further relates to pharmaceutical compositions comprising the aforementioned compounds.

Method for reducing the inflammation and inducing an analgesic effect and compounds thereof

Method for reducing inflammation and inducing an analgesic effect and compounds thereof

Quaternary pyridinium compounds for use as acetylcholinesterase inhibitors of the following formulas: ##STR1##

Quaternary pyridinium compounds and uses therefor

Quaternary pyridinium compounds, their use in inhibiting acetylcholinesterase, their roles in the prophylaxis and treatment of organophosphate poisoning, their roles in anticholinesterase therapy and their roles as agents mimicking or opposing the actions of the natural neurotransmitter acetylcholine.

Quaternary pyridinium compounds

The preparation of aminoalkyl phenyl selenides and pharmaceutically acceptable salts thereof is disclosed which are useful for the treatment of hypertension and related vascular diseases and the treatment of nervous system dysfunctions.

Aminoalkyl phenyl selenides for the treatment of hypertension and

Hypertension in mammals can be treated by administering an effective amount of an aminoalkyl phenyl sulfide having the formula ##STR1## wherein (C.sub.n H.sub.2n)=a linear or branched alkyl chain of 10 carbons or less (n=1-10);

Growing community of inventors

Atlanta, GA, United States of America

Sheldon W May